RecruitingNot applicableNCT04657042
Official study title

4D-MRI for Precision Medicine

Study summary

The purpose of this study is to develop new ways to make medical images of the lungs and liver of adults using a technique called four-dimensional magnetic resonance imaging (4D-MRI). This technique produces three-dimensional movies of the inside of the chest and abdomen while the patient is breathing. (The fourth dimension is time!) This new way of medical imaging is being developed to help cancer patients undergoing radiation therapy. Radiation therapy is used to treat cancerous tumors. For radiation therapy to be effective, the precise size, shape, and location of the tumor within the body must be known. A particular difficulty for radiation treatment of lung and liver cancer is that the tumor moves during treatment because the patient is breathing. Therefore, tumor motion must also be incorporated into the treatment plan. This study aims to improve radiation treatment planning through better targeting and dose estimation based on 4D-MRI. Before this new imaging method can be used for radiation treatment planning, it must be tested in living, breathing volunteers.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedMagnetic Resonance Imaging

The study team can explain what participation involves.

Who it may be forHealthy Volunteers · Liver Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 6, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Virginia

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Virginia
Interventions being studied
Diagnostic Test: Magnetic Resonance Imaging
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • The inclusion criteria for lung and liver cancer patients are:
  • Patient is 21 or older
  • Patient has primary or metastatic tumor(s) in the lungs or the liver
  • Diameter of the tumor(s) is less than 7 cm
  • Patient will receive radiation therapy (ordered by the treating Radiation Oncologist) as part of their treatment regimen
  • Patient will undergo a planning CT scan with tumor motion assessment (planning 4D-CT ordered by the treating Radiation Oncologist) as part of their treatment regimen
  • Patient has signed informed consent and is willing to comply with the 4D-MRI imaging protocol The inclusion criteria for healthy volunteers are:
  • Subject is 18 or older
  • Subject has signed informed consent and is willing to comply with the 4D-MRI imaging protocol
Reasons someone may not be able to joinExclusion criteria
  • Any condition for which a MRI procedure is contraindicated including presence of metallic material in the body, such as pacemakers, non- MRI compatible surgical clips, shrapnel, etc.
  • Subjects who have difficulty lying flat on their back for extended periods of time
  • Patients with any serious/poorly controlled medical or psychological conditions that would complicate protocol compliance
  • Too large to adequately fit in the magnet bore or RF coils
  • Claustrophobia
  • Females who are pregnant or lactating
  • Presence of active or chronic infection

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of VirginiaCharlottesville, Virginia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 6, 2026. Always confirm current availability with the study team.

View original record ↗